Drug Delivery Strategies in Maximizing Anti-Angiogenesis and Anti-Tumor Immunity

Researchers delve into the mechanisms behind anti-tumor immunity and seeks to identify the differential effect of dosing regimens, including daily low-dose and medium-dose intermittent chemotherapy, on both innate and adaptive immune populations involved in observed anti-tumor immune response.